FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

1149365000: Product containing precisely abacavir (as abacavir sulfate) 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Defined. Date: 31-Jul 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4555462016 Product containing precisely abacavir (as abacavir sulfate) 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core
4555463014 Abacavir (as abacavir sulfate) 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet en Synonym Active Case insensitive SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Abacavir (as abacavir sulfate) 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet Plays role Antiretroviral therapeutic role true Inferred relationship Some
Abacavir (as abacavir sulfate) 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet Has precise active ingredient Zidovudine true Inferred relationship Some 3
Abacavir (as abacavir sulfate) 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet Has BoSS Abacavir true Inferred relationship Some 2
Abacavir (as abacavir sulfate) 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet Has unit of presentation Tablet true Inferred relationship Some
Abacavir (as abacavir sulfate) 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet Has precise active ingredient Abacavir sulfate true Inferred relationship Some 2
Abacavir (as abacavir sulfate) 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 3
Abacavir (as abacavir sulfate) 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet Has BoSS Lamivudine true Inferred relationship Some 1
Abacavir (as abacavir sulfate) 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 2
Abacavir (as abacavir sulfate) 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 2
Abacavir (as abacavir sulfate) 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet Is a Abacavir and lamivudine and zidovudine only product in oral dose form true Inferred relationship Some
Abacavir (as abacavir sulfate) 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet Has precise active ingredient Lamivudine true Inferred relationship Some 1
Abacavir (as abacavir sulfate) 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 1
Abacavir (as abacavir sulfate) 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet Has BoSS Zidovudine true Inferred relationship Some 3
Abacavir (as abacavir sulfate) 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 3
Abacavir (as abacavir sulfate) 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet Has manufactured dose form Conventional release oral tablet true Inferred relationship Some
Abacavir (as abacavir sulfate) 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Description inactivation indicator reference set

REPLACED BY association reference set

Back to Start